Vir Biotechnology, Inc. · NASDAQ:VIR
de Verneuil Vanina sold 3,750 Vir Biotechnology, Inc. shares (Form 4)
Traded Nov 2 to Nov 3, 2026 · Filed Nov 4, 2026
From Nov 2 to Nov 3, 2026, de Verneuil Vanina (EVP, General Counsel, Corp Sec) sold 3,750 Vir Biotechnology, Inc. shares at an average US$11.18 for US$41,939 under a trading plan, leaving 110,193 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 3,750 shares
- Price
- US$11.18 average (US$11.10 to US$11.33)
- Value
- US$41,939
- Holding after
- 110,193 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, General Counsel, Corp Sec
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Sale | 1,343 | US$11.33 | 112,600 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 2,407 | US$11.10 | 110,193 | Direct |
Source
Download original · View original at SEC